Ladostigil, 6-(N- ethyl, N- methyl carbamyloxy)-N propargyl-1(R)-aminoindan hemitartrate, was originally designed as an acetylcholinesterase (AChE) and monoamine oxidase (MAO)-B inhibitor to treat subjects with AD and depression [120]. This evidence concerns the gene MAOB and Alzheimer disease.